Versant Side Fund IV, L.P.
CIK 0001456591 Name as filed on the most recent filing
Filed as Versant Side Fund IV, L.P. (6)
19 transaction lines · from 6 filings · filed 2011-11-17 to 2024-08-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.
- ISSUER Tempest Therapeutics, Inc. 1 filings
- ISSUER Oyster Point Pharma, Inc. 2 filings
- ISSUER Crispr Therapeutics AG 2 filings
- ISSUER Clovis Oncology, Inc. 1 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.
| Direction | Date | Code | Company | Value USD | Filing |
|---|---|---|---|---|---|
| 2024-08-12 | S, Open-market sale | Tempest Therapeutics, Inc.TPST | Open Form 4 filing 0000950170-24-095675 | ||
| 2024-08-08 | S, Open-market sale | Tempest Therapeutics, Inc.TPST | Open Form 4 filing 0000950170-24-095675 | ||
| 2021-10-18 | S, Open-market sale | Oyster Point Pharma, Inc.OYST | 4 lines | Open Form 4 filing 0000899243-21-040777 | |
| 2019-11-04 | P, Open-market purchase | Oyster Point Pharma, Inc.OYST | 3 lines | Open Form 4 filing 0000899243-19-026602 | |
| 2018-04-23 | S, Open-market sale | Crispr Therapeutics AGCRSP | 4 lines | Open Form 4 filing 0000899243-18-010684 | |
| 2016-10-24 | P, Open-market purchase | Crispr Therapeutics AGCRSP | 4 lines | Open Form 4 filing 0001104659-16-163806 | |
| 2011-11-16 | P, Open-market purchase | Clovis Oncology, Inc.CLVS | Not reported | Open Form 4 filing 0001104659-11-064948 | |
| 2011-11-16 | P, Open-market purchase | Clovis Oncology, Inc.CLVS | Not reported | Open Form 4 filing 0001104659-11-064948 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Versant Side Fund IV, L.P., insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001456591
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6